280.96

1.15% -3.27

Insulet Corporation (PODD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché PODD Giù? Forum Previsione

Precedente Chiudi:

$284.23

Aprire:

$284.655

Volume 24 ore:

376.48K

Relative Volume:

0.47

Capitalizzazione di mercato:

$19.77B

Reddito:

$2.20B

Utile/perdita netta:

$402.20M

Rapporto P/E:

50.53

EPS:

5.56

Flusso di cassa netto:

$280.80M

1 W Prestazione:

-3.78%

1M Prestazione:

-7.32%

6M Prestazione:

+1.77%

1 anno Prestazione:

+44.06%

Intervallo 1D:

$280.43

$288.00

Intervallo di 1 settimana:

$280.43

$293.17

Portata 52W:

$173.00

$329.33

Insulet Corporation Stock (PODD) Company Profile

Nome

Insulet Corporation

Settore

Healthcare (1161)

Industria

Medical Devices (147)

Telefono

978-600-7000

Indirizzo

100 NAGOG PARK, ACTON, MA

Dipendente

3,900

Cinguettio

@insulet_uk

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

PODD's Discussions on Twitter

Confronta PODD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PODD Insulet Corporation	280.96	20.55B	2.20B	402.20M	280.80M	5.56
ABT Abbott Laboratories	124.42	229.71B	43.11B	13.98B	6.66B	7.98
BSX Boston Scientific Corp	103.78	154.35B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	387.32	149.60B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	89.70	114.97B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	76.56	45.92B	5.54B	4.18B	623.10M	7.00

Insulet Corporation Stock (PODD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-16	Iniziato	Truist	Buy
2025-05-30	Iniziato	Goldman	Buy
2025-05-13	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2025-04-29	Downgrade	Wolfe Research	Outperform → Peer Perform
2025-03-06	Iniziato	RBC Capital Mkts	Outperform
2024-11-06	Iniziato	Bernstein	Outperform
2024-05-30	Iniziato	Redburn Atlantic	Buy
2024-05-07	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2023-12-21	Aggiornamento	Robert W. Baird	Neutral → Outperform
2023-12-04	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2023-10-02	Aggiornamento	Jefferies	Hold → Buy
2023-08-21	Aggiornamento	Citigroup	Neutral → Buy
2023-08-21	Downgrade	Robert W. Baird	Outperform → Neutral
2023-05-30	Ripresa	Morgan Stanley	Equal-Weight
2023-01-26	Iniziato	Wolfe Research	Peer Perform
2022-11-04	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-10-18	Iniziato	Barclays	Equal Weight
2022-10-12	Iniziato	Jefferies	Hold
2022-07-11	Downgrade	Citigroup	Buy → Neutral
2022-03-02	Ripresa	BofA Securities	Buy
2022-02-03	Aggiornamento	BTIG Research	Neutral → Buy
2022-02-02	Aggiornamento	UBS	Neutral → Buy
2022-01-31	Aggiornamento	Oppenheimer	Perform → Outperform
2021-07-21	Ripresa	Cowen	Outperform
2021-05-25	Iniziato	Barclays	Overweight
2021-04-01	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2021-03-19	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-01-29	Downgrade	Piper Sandler	Overweight → Neutral
2020-12-16	Downgrade	Citigroup	Buy → Neutral
2020-07-28	Iniziato	Wells Fargo	Overweight
2020-04-24	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-04-03	Iniziato	BofA/Merrill	Neutral
2020-03-31	Downgrade	Berenberg	Buy → Hold
2020-03-05	Iniziato	Citigroup	Buy
2019-12-10	Iniziato	CFRA	Sell
2019-10-23	Iniziato	Stifel	Hold
2019-10-18	Downgrade	Canaccord Genuity	Buy → Hold
2019-10-14	Downgrade	BTIG Research	Buy → Neutral
2019-10-04	Downgrade	UBS	Buy → Neutral
2019-10-03	Downgrade	Guggenheim	Buy → Neutral
2019-08-06	Aggiornamento	JP Morgan	Neutral → Overweight
2019-06-10	Downgrade	Northland Capital	Outperform → Market Perform
2019-05-06	Aggiornamento	BTIG Research	Neutral → Buy
2018-04-20	Iniziato	Berenberg	Buy
2018-02-22	Reiterato	Barclays	Overweight
2018-01-08	Aggiornamento	Raymond James	Mkt Perform → Outperform
2017-11-03	Aggiornamento	Canaccord Genuity	Hold → Buy
2017-09-15	Iniziato	Barclays	Overweight

Mostra tutto

Insulet Corporation Borsa (PODD) Ultime notizie

01:35 AM

What analysts say about Insulet Corporation stockHigh-profit trading signals - jammulinksnews.com

01:35 AM

Jul 21, 2025

Is Insulet Corporation a good long term investmentHigh-yield market plays - Autocar Professional

Jul 21, 2025

Digital Diabetes Management Market is projected to reach US$ - openPR.com

Jul 21, 2025

Jul 20, 2025

Insulet Corporation Stock Analysis and ForecastTremendous return on equity - Autocar Professional

Jul 20, 2025

What drives Insulet Corporation stock priceOutstanding risk-reward balance - Autocar Professional

Jul 20, 2025

Jul 17, 2025

$1000 Invested In Insulet 10 Years Ago Would Be Worth This Much Today - Benzinga

Jul 17, 2025

Navigating the Crossroads: Insulet's Short-Term Volatility and Long-Term Growth Potential - AInvest

Jul 17, 2025

Jul 11, 2025

Insulet's PODD Stock Plunges 2.72% Amid Market Uncertainty - AInvest

Jul 11, 2025

Jul 10, 2025

Smart Pumps Market is projected to reach USD 19.96 billion by 2033 - openPR.com

Jul 10, 2025

Jul 09, 2025

Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance

Jul 09, 2025

Jul 08, 2025

Leading Insulin Pump Maker Insulet to Release Q2 2025 Results August 7Key Details for Investors - Stock Titan

Jul 08, 2025

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire

Jul 08, 2025

Jul 07, 2025

Trading (PODD) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 07, 2025

Jul 06, 2025

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? - MSN

Jul 06, 2025

Jun 30, 2025

Insulet Stock Plummets 30.61% with $196M Trading Volume Ranking 493rd Amid Omnipod 5 Recall - AInvest

Jun 25, 2025

Jun 24, 2025

How Is Insulet's Stock Performance Compared To Other Medical Devices Stocks? - Barchart.com

Jun 24, 2025

Jun 23, 2025

Insulet’s Eric Benjamin shares update on automated insulin delivery system - MedTech Dive

Jun 23, 2025

Jun 19, 2025

5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions - Business Wire

Jun 19, 2025

Jun 17, 2025

Truist bullish on diabetes companies citing potential market growth - MSN

Jun 17, 2025

Insulet’s SWOT analysis: patch pump leader’s stock poised for growth By Investing.com - Investing.com South Africa

Jun 17, 2025

Insulet’s SWOT analysis: patch pump leader’s stock poised for growth - Investing.com

Jun 17, 2025

Jun 16, 2025

Analyst Predicts Strong Growth for Insulet (PODD) with Buy Ratin - GuruFocus

Jun 16, 2025

Insider Sell: Dan Manea Sells 1,300 Shares of Insulet Corp (PODD) - GuruFocus

Jun 16, 2025

Insulet, EyePoint & NanoDx receive $2M in tax incentives to create life sciences jobs - Worcester Business Journal

Jun 16, 2025

Insulet (PODD) Rated 'Buy' by Truist Securities; Price Target Set at $365 | PODD Stock News - GuruFocus

Jun 16, 2025

(PODD) Investment Report - news.stocktradersdaily.com

Jun 16, 2025

Truist initiates Insulet stock with buy rating on diabetes pump potential - Investing.com Nigeria

Jun 16, 2025

Truist Initiates Insulet at Buy With $365 Price Target - MarketScreener

Jun 16, 2025

Truist Securities Starts Insulet Corporation (PODD) at Buy - StreetInsider

Jun 16, 2025

Jun 13, 2025

Insulet’s SWOT analysis: pump maker’s stock rides wave of growth By Investing.com - Investing.com South Africa

Jun 13, 2025

Insulet’s SWOT analysis: pump maker’s stock rides wave of growth - Investing.com

Jun 13, 2025

Trade secret misappropriation: permanent injunction and monetary damages - Reuters

Jun 13, 2025

Here's Why You Should Retain PODD Stock in Your Portfolio Now - MSN

Jun 13, 2025

Jun 12, 2025